PREGNANCY: Clomipramine has not been adequately evaluated in pregnant women. Due to the lack of conclusive safety data, clomipramine should be used in pregnancy only if the benefit justifies the potential risk to the fetus. Clomipramine is classified as FDA pregnancy risk category C.
NURSING MOTHERS: Clomipramine is excreted into breast milk. Due to the lack of safety data, clomipramine is not recommended for use in females who are breastfeeding.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.